Epidermal Growth Factor Receptor Antagonists in Pancreatic Cancer: What is Their Role?

By Tang Patricia A.   Moore Malcolm J.  

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 213-221

Adis International

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor-Targeted Therapy for Pancreatic Cancer

By Papageorgio Chris   Perry Michael  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 647-657

Informa Healthcare

Access to resources Recommend Favorite

Expression of Heparin-Binding Epidermal Growth Factor-like Growth Factor in Pancreatic Adenocarcinoma

By Ito Yasuhiro   Higashiyama Shigeki   Takeda Tsutomu   Yamamoto Yasuko   Wakasa Ken-ichi   Matsuura Nariaki  

International Journal of Gastrointestinal Cancer, Vol. 29, Iss. 1, 2001-02 ,pp. : 47-52

Humana Press, Inc

Access to resources Recommend Favorite

Serum and Correspondent Tissue Measurements of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGF-R): Clinical Relevance in Pancreatic Cancer and Chronic Pancreatitis

By  

International Journal of Gastrointestinal Cancer, Vol. 25, Iss. 2, 1999-04 ,pp. : 89-96

Humana Press, Inc

Access to resources Recommend Favorite

Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface

By                  

Oncology Reports, Vol. 34, Iss. 1, 2015-01 ,pp. : 350-358

Spandidos Publications

Access to resources Recommend Favorite